GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioteque Corp (ROCO:4107) » Definitions » Enterprise Value

Bioteque (ROCO:4107) Enterprise Value : NT$8,147 Mil (As of Jun. 24, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Bioteque Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bioteque's Enterprise Value is NT$8,147 Mil. Bioteque's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was NT$616 Mil. Therefore, Bioteque's EV-to-EBIT ratio for today is 13.22.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Bioteque's Enterprise Value is NT$8,147 Mil. Bioteque's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was NT$773 Mil. Therefore, Bioteque's EV-to-EBITDA ratio for today is 10.54.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Bioteque's Enterprise Value is NT$8,147 Mil. Bioteque's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was NT$1,985 Mil. Therefore, Bioteque's EV-to-Revenue ratio for today is 4.10.


Bioteque Enterprise Value Historical Data

The historical data trend for Bioteque's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioteque Enterprise Value Chart

Bioteque Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,867.06 8,125.71 7,096.33 7,331.77 6,952.38

Bioteque Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,285.79 7,371.45 6,892.20 6,952.38 7,904.27

Competitive Comparison of Bioteque's Enterprise Value

For the Medical Instruments & Supplies subindustry, Bioteque's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioteque's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioteque's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Bioteque's Enterprise Value falls into.



Bioteque Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Bioteque's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Bioteque's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioteque  (ROCO:4107) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Bioteque's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=8146.811/616.174
=13.22

Bioteque's current Enterprise Value is NT$8,147 Mil.
Bioteque's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$616 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Bioteque's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=8146.811/772.709
=10.54

Bioteque's current Enterprise Value is NT$8,147 Mil.
Bioteque's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$773 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Bioteque's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=8146.811/1985.026
=4.10

Bioteque's current Enterprise Value is NT$8,147 Mil.
Bioteque's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,985 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioteque Enterprise Value Related Terms

Thank you for viewing the detailed overview of Bioteque's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioteque (ROCO:4107) Business Description

Traded in Other Exchanges
N/A
Address
Chang-An E. Road, 5th Floor-6, No.23, Section 1, Taipei, TWN, 104
Bioteque Corp is a Manufacturing, trading, and seller of medical equipment and instruments and Reinvestment and monopoly investment in the securities business. The company operates in three different segments. 1. Segment A: manufacturing medical disposables for hemodialysis use, and selling them to global dealers and retailers. 2. Segment B: manufacturing and selling catheters for healthcare and medical PVC IV bag to medical organizations. 3. Segment C: manufacturing and selling medical key components and inner catheters to the medical organization.

Bioteque (ROCO:4107) Headlines

No Headlines